UM  > 中華醫藥研究院
Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: A protocol for network meta-analysis of randomised controlled trials
Jia Y.2; Zhu H.2; Leung S.-W.2
2016-06-01
Source PublicationBMJ Open
ISSN20446055
Volume6Issue:6
AbstractIntroduction There have been inconsistent findings from randomised controlled trials (RCTs) and systematic reviews on the efficacies of selective serotonin reuptake inhibitors (SSRIs) as the first-line treatment of major depressive disorder (MDD). Besides inconsistencies among randomised controlled trials (RCTs), their risks of bias and evidence grading have seldom been evaluated in meta-analysis. This study aims to compare the efficacy of SSRIs by conducting a Bayesian network meta-analysis, which will be the most comprehensive evaluation of evidence to resolve the inconsistency among previous studies. Methods and analyses SSRIs including citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline and vilazodone have been selected. Systematic database searching and screening will be conducted for the RCTs on drug treatment of patients with MDD according to pre-specified search strategies and selection criteria. PubMed, the Cochrane Library, EMBASE, ScienceDirect, the US Food and Drug Administration Website, ClinicalTrial.gov and WHO Clinical Trials will be searched. Outcome data including Hamilton Depression Rating Scale (HDRS), Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression (CGI) from eligible RCTs will be extracted. The outcomes will be analysed as ORs and mean differences under a random-effects model. A Bayesian network meta-analysis will be conducted with WinBUGS software, to compare the efficacies of SSRIs. Subgroup and sensitivity analysis will be performed to explain the study heterogeneity and evaluate the robustness of the results. Meta-regression analysis will be conducted to determine the possible factors affecting the efficacy outcomes. The Cochrane risk of bias assessment tool will be used to assess the RCT quality, and the Grading of Recommendation, Assessment, Development and Evaluation will be used to assess the strength of evidence from the meta-analysis. Ethics and dissemination No ethical approval is required because this study includes neither confidential personal patient data nor interventions with patients.
DOI10.1136/bmjopen-2015-010142
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:4   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.University of Edinburgh
2.Universidade de Macau
Recommended Citation
GB/T 7714
Jia Y.,Zhu H.,Leung S.-W.. Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: A protocol for network meta-analysis of randomised controlled trials[J]. BMJ Open,2016,6(6).
APA Jia Y.,Zhu H.,&Leung S.-W..(2016).Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: A protocol for network meta-analysis of randomised controlled trials.BMJ Open,6(6).
MLA Jia Y.,et al."Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: A protocol for network meta-analysis of randomised controlled trials".BMJ Open 6.6(2016).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Jia Y.]'s Articles
[Zhu H.]'s Articles
[Leung S.-W.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Jia Y.]'s Articles
[Zhu H.]'s Articles
[Leung S.-W.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Jia Y.]'s Articles
[Zhu H.]'s Articles
[Leung S.-W.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.